Author:
Liu Ju-E,Ren Bin,Tang Lan,Tang Qian-Jie,Liu Xiao-Ying,Li Xin,Bai Xue,Zhong Wan-Ping,Meng Jin-Xiu,Lin Hao-Ming,Wu Hong,Chen Ji-Yan,Zhong Shi-Long
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Lins, R. L. et al. Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. Nephrol Dial Transplant. 18, 967–976 (2003).
2. Jacobsen, W. et al. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos. 28, 1369–78 (2000).
3. Christians, U., Jacobsen, W. & Floren, L. C. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther. 80, 1–34 (1998).
4. Park, J. E. et al. Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin. Xenobiotica. 38, 1240–51 (2008).
5. Prueksaritanont, T. et al. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Drug Metab Dispos. 25, 1191–9 (1997).
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献